Volume 19, Number 5—May 2013
Campylobacter coli Outbreak in Men Who Have Sex with Men, Quebec, Canada, 2010–2011
|Antimicrobial agent†||MIC (mg/L)||Interpretation|
*S, susceptible; R, resistant; NA, not available; –, not applicable.
†The susceptibility and resistance breakpoints were Clinical and Laboratory Standards Institute (CLSI) Campylobacter breakpoints for erythromycin, tetracycline and ciprofloxacin (10), National Antimicrobial Resistance Monitoring System Campylobacter breakpoints for azithromycin and clindamycin (11), no breakpoints available for tigecycline and CLSI Enterobacteriaceae breakpoints for the 6 other antimicrobial agents (12).
‡β-lactamase susceptibility was determined as described (9).
- Page created: April 16, 2013
- Page last updated: April 16, 2013
- Page last reviewed: April 16, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)